Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 355
Gene Symbol: FAS
FAS
0.180 GeneticVariation disease BEFREE Individuals with germline mutations in the Fas gene have a high risk to develop non Hodgkin lymphomas (x 14) as well as Hodgkin lymphomas (x 51), in particular NLP Hodgkin lymphoma. 15160902 2004
Entrez Id: 355
Gene Symbol: FAS
FAS
0.180 GeneticVariation disease BEFREE Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma. 12507887 2003
Entrez Id: 355
Gene Symbol: FAS
FAS
0.180 GeneticVariation disease BEFREE Because ALPS and NLP HL are both highly infrequent conditions, the occurrence in at least 3 families suggests a causative relationship between germline FAS gene mutations and NLP HL. 11830507 2002
Entrez Id: 355
Gene Symbol: FAS
FAS
0.180 Biomarker disease BEFREE These data demonstrate that caspase-3 expression plays an important role in CD95-mediated apoptosis in HD cell lines. 11376869 2001
Entrez Id: 355
Gene Symbol: FAS
FAS
0.180 Biomarker disease BEFREE As Hodgkin-Reed-Sternberg cells are resistant to CD95-mediated apoptosis and chromosomal aberrations involving the 1p22 region harbouring the proapoptotic BCL10 gene represent a recurrent event in Hodgkin's disease-derived cell lines, analysis of the BCL10 gene and its transcripts was performed. 10848834 2000
Entrez Id: 355
Gene Symbol: FAS
FAS
0.180 GeneticVariation disease BEFREE We describe the molecular analysis of the CD95 death domain in a family with autoimmune lymphoproliferative syndrome (Canale-Smith syndrome), T-cell lymphoma, and Hodgkin's disease. 10340403 1999
Entrez Id: 355
Gene Symbol: FAS
FAS
0.180 Biomarker disease BEFREE These results suggest possible hyper-expression of FAS/APO-1 (CD95) in Hodgkin's disease and anaplastic large cell lymphomas. 8522287 1995
Entrez Id: 355
Gene Symbol: FAS
FAS
0.180 GeneticVariation disease BEFREE No fas/APO-1 alterations were observed in the 31 HD cases. 7572793 1995
Entrez Id: 355
Gene Symbol: FAS
FAS
0.180 Biomarker disease HPO